Data / Form D filings / Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc.: Form D filings
Mersana Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 9 Form D notices with the SEC between 2010 and 2016. The latest, on June 24, 2016, reports $33.1 million sold of a $33.1 million offering to 13 investors.
Find out what Mersana Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 840 MEMORIAL DRIVE, Cambridge, MA, 02139
- Phone
- (617) 498-0020
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1442836
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2016 | New notice | $33,099,988 | $33,099,988 | $0 | 13 | Jun 15, 2016 | sec.gov |
| Mar 1, 2016 | Amendment | $35,450,006 | $10,128,576 | $25,321,430 | 10 | Feb 20, 2015 | sec.gov |
| Mar 3, 2015 | New notice | $35,450,006 | $10,128,576 | $25,321,430 | 10 | Feb 20, 2015 | sec.gov |
| Apr 8, 2014 | Amendment | $14,505,371 | $14,505,371 | $0 | 10 | Sep 27, 2013 | sec.gov |
| Oct 9, 2013 | New notice | $14,499,542 | $4,999,994 | $9,499,548 | 7 | Sep 27, 2013 | sec.gov |
| Aug 9, 2012 | New notice | $26,999,708 | $12,500,164 | $14,499,544 | 12 | Jul 27, 2012 | sec.gov |
| Apr 18, 2012 | Amendment | $10,000,000 | $10,000,000 | $0 | 7 | Apr 12, 2011 | sec.gov |
| Apr 21, 2011 | New notice | $10,000,000 | $6,000,000 | $4,000,000 | 7 | Apr 12, 2011 | sec.gov |
| Feb 26, 2010 | New notice | $3,500,000 | $2,500,000 | $1,000,000 | 7 | Jan 19, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| TIMOTHY LOWINGER | Executive Officer | |
| DAVID MOTT | Director | |
| ELAINE J. JONES | Director | |
| MICHAEL J. KAUFMAN | Executive Officer | |
| THOMAS J. BECK | Director | |
| ANNA PROTOPAPAS | Executive Officer, Director | |
| EVA JACK | Executive Officer | |
| DONALD BERGSTROM | Executive Officer | |
| SARA J. NAYEEM | Director | |
| WAYNE J. FOSTER | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Jun 20, 2016 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mersana Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.